Amrutanjan Health Care Limited (AMRUTANJAN) — Announcement

📢 Key Event
Amrutanjan Health Care reported FY26 growth with double-digit segment performance and new product launches.

🔄 What Changed
Double-digit growth in Pain Management and Women's Hygiene segments

🔮 What's Next
Relaunch Congestion brand and expand Sanitary Pad plant production in May

💡 Investor Takeaway
Shareholders benefit from strong growth in core brands and expanded market reach.

Amrutanjan Health Care Limited reported strong FY26 growth driven by double-digit gains in Pain Management and Women's Hygiene segments, with new product launches expanding its portfolio into razors and antiseptic plasters. The company increased distribution by 12% and salesman productivity by 8%, supporting a 35% rise in total lines sold. Management highlighted confidence in future demand, plans to relaunch the Congestion brand, and ongoing digitization efforts to enhance operational efficiency. The presentation emphasized strategic expansion into rural markets through van initiatives and targeted marketing campaigns to boost brand visibility and consumer engagement.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMRUTANJAN ✨ Ask AI About This